These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7634560)

  • 1. Antihypertensive therapy targeted to the needs of the patient: focus on the renin-angiotensin system; older and newer agents.
    Itskovitz HD
    Clin Cardiol; 1995 Jun; 18(6 Suppl 3):III 23-8. PubMed ID: 7634560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive advantages of angiotensin II AT1 receptor antagonism].
    Coca A; Giner V
    Rev Esp Cardiol; 1999; 52 Suppl 3():53-8. PubMed ID: 10614150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor blockers. A new class of antihypertensive drugs.
    Velasquez MT
    Arch Fam Med; 1996 Jun; 5(6):351-6. PubMed ID: 8640326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
    Ellis ML; Patterson JH
    Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Angiotensin-II receptor blockers].
    Metelitsa VI
    Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
    [No Abstract]   [Full Text] [Related]  

  • 6. [Angiotensin II antagonists: a distinct therapeutic class].
    Waeber B; Brunner HR
    Presse Med; 1996 Oct; 25(32):1533-5. PubMed ID: 8952659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with angiotensin II receptor antagonists.
    Brunner HR; Christen Y; Munafo A; Lee RJ; Waeber B; Nussberger J
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):243S-246S. PubMed ID: 1290619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renin-angiotensin system blockade. What can be expected from angiotensin II antagonists?].
    Waeber B; Nussberger J; Brunner H
    Rev Prat; 1992 Oct; 42(16):2066-8. PubMed ID: 1485114
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists: the prototype losartan.
    Schaefer KL; Porter JA
    Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Losartan: first of a new class of angiotensin antagonists for the management of hypertension.
    Carr AA; Prisant LM
    J Clin Pharmacol; 1996 Jan; 36(1):3-12. PubMed ID: 8932538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future role of losartan.
    Hansson L
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
    Burrell LM
    Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the chemical development of angiotensin II receptor antagonists.
    Wexler RR; Carini DJ; Duncia JV; Johnson AL; Wells GJ; Chiu AT; Wong PC; Timmermans PB
    Am J Hypertens; 1992 Dec; 5(12 Pt 2):209S-220S. PubMed ID: 1290616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.
    Foote EF; Halstenson CE
    Ann Pharmacother; 1993 Dec; 27(12):1495-503. PubMed ID: 8305785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II receptor inhibition. A new therapeutic principle.
    Messerli FH; Weber MA; Brunner HR
    Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II receptor antagonists. Potential in elderly patients with cardiovascular disease.
    Burrell LM; Johnston CI
    Drugs Aging; 1997 Jun; 10(6):421-34. PubMed ID: 9205848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hypertensive therapy by losartan. How effective is AT1 receptor blockade?
    Brunner HR
    J Hum Hypertens; 1995 Nov; 9(11):859-60. PubMed ID: 8583462
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
    Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
    J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensin II receptor antagonist losartan: a new advance in the treatment of hypertension.
    Lacourcière Y
    Can J Cardiol; 1995 Aug; 11 Suppl F():45F-48F. PubMed ID: 7664218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
    Dahlöf B
    J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.